This page in English
Laddar profil information

Publikationer

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
Törlén J, Gaballa A, Remberger M, Mörk Lm, Sundberg B, Mattsson J, et al
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019;():-

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
Rådestad E, Sundin M, Törlén J, Thunberg S, Önfelt B, Ljungman P, et al
Frontiers in immunology 2019;10():189-

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease
Stikvoort A, Chen Y, Rådestad E, Törlén J, Lakshmikanth T, Björklund A, et al
Frontiers in immunology 2017;8():717-

Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions
Törlén J, Remberger M, Le Blanc K, Ljungman P, Mattsson J
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017;23(4):677-683

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
Remberger M, Törlen J, Serafi Ie, Garming-legert K, Björklund A, Ljungman P, et al
International journal of hematology 2017;106(4):471-475

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation
Törlén J, Ringdén O, Garming-legert K, Ljungman P, Winiarski J, Remes K, et al
Haematologica 2016;101(11):1417-1425

Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation
Blennow O, Remberger M, Törlén J, Szakos A, Ljungman P, Mattsson J
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016;22(9):1684-1689

Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
Remberger M, Törlén J, Ringdén O, Engström M, Watz E, Uhlin M, et al
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015;21(5):889-93

Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients
Swartling L, Allard A, Torlen J, Ljungman P, Mattsson J, Sparrelid E
TRANSPLANT INFECTIOUS DISEASE 2015;17(6):785-94

Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital
Ringdén O, Remberger M, Törlén J, Engström M, Fjaertoft G, Mattsson J, et al
Pediatric transplantation 2014;18(4):398-404

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome
Törlén J, Ringdén O, Le Rademacher J, Batiwalla M, Chen J, Erkers T, et al
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014;20(9):1418-25

Visa alla publikationer

Map

View map

Z1:00, Karolinska Universitetssjukhuset Solna
Stockholm